Condensed Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2012	Sep. 30, 2011
ASSETS
Cash and cash equivalents	$ 3,941,042	$ 4,260,594
Receivables	158,614	457,337
Prepaid expenses	1,306,041	2,028,531
Inventory used for R&D and manufacturing	1,384,484	1,571,182
Deferred rent - current portion	651,768	703,274
Total current assets	7,441,949	9,020,918
RESEARCH AND OFFICE EQUIPMENT AND LEASEHOLD IMPROVEMENTS - less accumulated depreciation and amortization of $2,711,792 and $3,034,018	630,948	1,032,881
PATENT COSTS - less accumulated amortization of $1,313,046 and $1,287,323	384,278	414,158
DEFERRED RENT - net of current portion	5,939,358	6,486,566
DEPOSITS	1,670,917	1,670,917
TOTAL ASSETS	16,067,450	18,625,440
LIABILITIES AND STOCKHOLDERS' EQUITY
Accounts payable	592,867	738,951
Accrued expenses	191,214	290,220
Due to employees	20,178	22,789
Related party loan	1,104,057	1,104,057
Deferred rent - current portion	4,195
Convertible notes		4,999,000
Derivative instruments - current portion		69,552
Total current liabilities	1,912,511	7,224,569
Derivative instruments - net of current portion	6,983,690	2,192,521
Deferred revenue	126,500	125,000
Deferred rent-net of current portion	12,317	4,526
Deposits held	5,000
Total liabilities	9,040,018	9,546,616
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY
Preferred stock, $.01 par value; authorized, 200,000 shares; no shares issued and outstanding	0	0
Common stock, $.01 par value - authorized 600,000,000 shares, 273,113,332 issued and outstanding as of September 30, 2012 and authorized 450,000,000 shares; 214,723,023 shares issued and outstanding at September 30, 2011	2,731,133	2,147,230
Additional paid-in capital	207,285,920	194,443,905
Accumulated deficit	(202,989,621)	(187,512,311)
Total stockholders' equity	7,027,432	9,078,824
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 16,067,450	$ 18,625,440